These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 27045030)
41. A Novel Role of Cyclic Nucleotide Phosphodiesterase 10A in Pathological Cardiac Remodeling and Dysfunction. Chen S; Zhang Y; Lighthouse JK; Mickelsen DM; Wu J; Yao P; Small EM; Yan C Circulation; 2020 Jan; 141(3):217-233. PubMed ID: 31801360 [TBL] [Abstract][Full Text] [Related]
42. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure. Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233 [TBL] [Abstract][Full Text] [Related]
43. USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor. Zhang L; Zhou F; Drabsch Y; Gao R; Snaar-Jagalska BE; Mickanin C; Huang H; Sheppard KA; Porter JA; Lu CX; ten Dijke P Nat Cell Biol; 2012 Jun; 14(7):717-26. PubMed ID: 22706160 [TBL] [Abstract][Full Text] [Related]
44. Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT/GSK3β signaling. Huang Y; Wu D; Zhang X; Jiang M; Hu C; Lin J; Tang J; Wu L Gene; 2014 Feb; 536(2):225-31. PubMed ID: 24378234 [TBL] [Abstract][Full Text] [Related]
45. Novel role of mitochondrial GTPases 1 in pathological cardiac hypertrophy. Xu D; Zhao Y; Weng X; Lu Y; Li W; Tang K; Chen W; Liu Z; Qi X; Zheng J; Fassett J; Zhang Y; Xu Y J Mol Cell Cardiol; 2019 Mar; 128():105-116. PubMed ID: 30707992 [TBL] [Abstract][Full Text] [Related]
46. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy. Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292 [TBL] [Abstract][Full Text] [Related]
47. AKT regulation of mesothelial-to-mesenchymal transition in peritoneal dialysis is modulated by Smurf2 and deubiquitinating enzyme USP4. Xiao L; Peng X; Liu F; Tang C; Hu C; Xu X; Wang M; Luo Y; Yang S; Song P; Xiao P; Kanwar YS; Sun L BMC Cell Biol; 2015 Mar; 16():7. PubMed ID: 25885904 [TBL] [Abstract][Full Text] [Related]
48. Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis. Xing C; Lu XX; Guo PD; Shen T; Zhang S; He XS; Gan WJ; Li XM; Wang JR; Zhao YY; Wu H; Li JM Cancer Res; 2016 Jan; 76(1):83-95. PubMed ID: 26669864 [TBL] [Abstract][Full Text] [Related]
50. Overexpression of Ubiquitin-Specific Protease 2 (USP2) in the Heart Suppressed Pressure Overload-Induced Cardiac Remodeling. Xing J; Li P; Hong J; Wang M; Liu Y; Gao Y; Dong J; Gu H; Li L Mediators Inflamm; 2020; 2020():4121750. PubMed ID: 32963492 [TBL] [Abstract][Full Text] [Related]
51. Type III Transforming Growth Factor-β Receptor Drives Cardiac Hypertrophy Through β-Arrestin2-Dependent Activation of Calmodulin-Dependent Protein Kinase II. Lou J; Zhao D; Zhang LL; Song SY; Li YC; Sun F; Ding XQ; Yu CJ; Li YY; Liu MT; Dong CJ; Ji Y; Li H; Chu W; Zhang ZR Hypertension; 2016 Sep; 68(3):654-66. PubMed ID: 27432858 [TBL] [Abstract][Full Text] [Related]
52. Loss of TRADD attenuates pressure overload-induced cardiac hypertrophy through regulating TAK1/P38 MAPK signalling in mice. Wu L; Cao Z; Ji L; Mei L; Jin Q; Zeng J; Lin J; Chu M; Li L; Yang X Biochem Biophys Res Commun; 2017 Feb; 483(2):810-815. PubMed ID: 28013046 [TBL] [Abstract][Full Text] [Related]
53. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547 [TBL] [Abstract][Full Text] [Related]
54. USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes. Ye B; Zhou H; Chen Y; Luo W; Lin W; Zhao Y; Han J; Han X; Huang W; Wu G; Wang X; Liang G Circ Res; 2023 Feb; 132(4):465-480. PubMed ID: 36722348 [TBL] [Abstract][Full Text] [Related]
55. USP4 inhibits p53 through deubiquitinating and stabilizing ARF-BP1. Zhang X; Berger FG; Yang J; Lu X EMBO J; 2011 Jun; 30(11):2177-89. PubMed ID: 21522127 [TBL] [Abstract][Full Text] [Related]
57. H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT. Matsuda T; Jeong JI; Ikeda S; Yamamoto T; Gao S; Babu GJ; Zhai P; Del Re DP Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193718 [TBL] [Abstract][Full Text] [Related]
58. USP4 inhibits SMAD4 monoubiquitination and promotes activin and BMP signaling. Zhou F; Xie F; Jin K; Zhang Z; Clerici M; Gao R; van Dinther M; Sixma TK; Huang H; Zhang L; Ten Dijke P EMBO J; 2017 Jun; 36(11):1623-1639. PubMed ID: 28468752 [TBL] [Abstract][Full Text] [Related]
59. Cardiomyocyte-derived USP28 negatively regulates antioxidant response and promotes cardiac hypertrophy via deubiquitinating TRIM21. Han J; Lin L; Fang Z; Ye B; Han X; Xu J; Han B; Min J; Qian J; Wu G; Wang Y; Liang G Theranostics; 2024; 14(16):6236-6248. PubMed ID: 39431010 [No Abstract] [Full Text] [Related]
60. TBC1D25 Regulates Cardiac Remodeling Through TAK1 Signaling Pathway. Guo S; Liu Y; Gao L; Xiao F; Shen J; Xing S; Yang F; Zhang W; Shi Q; Li Y; Zhao L Int J Biol Sci; 2020; 16(8):1335-1348. PubMed ID: 32210723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]